BioSenic SA
BIOS | XBRU
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and inflammatory diseases. BioSenic has a broad and diverse portfolio of solutions in clinical development in a variety of therapeutic areas targeting markets characterized by significant unmet medical needs and limited innovation.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-31 07:00 |
Major Shareholding Notification
BIOS_PR_2025_March_Denominator_EN.pdf
|
English | 285.4 KB | |
| 2025-03-31 07:00 |
Major Shareholding Notification
BIOS_PR_2025_mars_Denominator_FR.pdf
|
French | 249.4 KB | |
| 2025-03-04 21:00 |
Regulatory News Service
BIOS_PR_20250304_EN.pdf
|
English | 275.4 KB | |
| 2025-03-04 21:00 |
Regulatory News Service
BIOS_PR_20250304_FR.pdf
|
French | 237.3 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_January_Denominator_EN.pdf
|
English | 287.5 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_janvier_Denominator_FR.pdf
|
French | 252.0 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_December_Denominator_EN.pdf
|
English | 288.4 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_décembre_Denominator_FR.pdf
|
French | 251.6 KB | |
| 2025-01-23 21:00 |
Regulatory News Service
BIOS_PR_2025-01-23_Transparency Notification_CGE_EN.pdf
|
English | 283.5 KB | |
| 2025-01-23 21:00 |
Major Shareholding Notification
BIOS_PR_2025-01-23_Transparency Notification_CGE_FR_.pdf
|
French | 249.7 KB | |
| 2025-01-03 00:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_03012025-EN.pdf
|
English | 318.0 KB | |
| 2025-01-03 00:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_03012025-FR.pdf
|
French | 274.6 KB | |
| 2024-12-13 00:00 |
Regulatory News Service
BioSenic - PR TrialCap (EN) - final.pdf
|
English | 242.5 KB | |
| 2024-12-13 00:00 |
Regulatory News Service
BioSenic - PR TrialCap - final.pdf
|
French | 280.9 KB | |
| 2024-10-31 18:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_October_Denominator_EN_final.pdf
|
English | 283.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-24 | Rieger Francois | Board | Sell | 1,800,000 | 17,460.00 EUR |
| 2024-07-23 | Rieger Francois | Board | Sell | 3,835,063 | 41,329.76 EUR |
| 2024-07-23 | POMI SCHNEITER VERONIQUE | Board | Sell | 35,367 | 371.35 EUR |
| 2024-07-22 | POMI SCHNEITER VERONIQUE | Board | Sell | 63,616 | 680.69 EUR |
| 2024-07-19 | POMI SCHNEITER VERONIQUE | Board | Sell | 60,419 | 664.61 EUR |
| 2024-07-18 | POMI SCHNEITER VERONIQUE | Board | Sell | 166,692 | 1,883.62 EUR |
| 2024-07-18 | Rieger Francois | Board | Sell | 2,541,231 | 33,572.44 EUR |
| 2024-07-17 | POMI SCHNEITER VERONIQUE | Board | Sell | 294,983 | 3,480.80 EUR |
| 2024-07-16 | POMI SCHNEITER VERONIQUE | Board | Sell | 210,562 | 2,758.36 EUR |
| 2024-07-11 | POMI SCHNEITER VERONIQUE | Board | Sell | 1,413,303 | 19,079.59 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |